J Cancer Prev 2021; 26(1): 32-40
Published online March 30, 2021
© Korean Society of Cancer Prevention
1Department of Obstetrics & Gynecology, 2Division of Biostatistics, 3Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, 4Department of Pathology, Johns Hopkins University, Baltimore, MD, 5Department of Pathology, The Ohio State University, Columbus, OH, 6Department of Hematology and Hematopoietic Cell Transplantation, Comprehensive Cancer Center, City of Hope National Medical Center, Duarte, CA, USA
Correspondence to :
Li-Shu Wang, E-mail: firstname.lastname@example.org, https://orcid.org/0000-0002-6500-6943
Jianhua Yu, E-mail: email@example.com, https://orcid.org/0000-0002-0326-3223
*These authors contributed equally to this work as co-first authors.
**These authors contributed equally to this work as co-correspondence authors.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Free fatty acid receptor 2 (
Keywords: Ffar2, ApcMin/+, Colorectal cancer, Metabolomics, Gut microbiota
Bantalem Tilaye Atinafu, Fekadu Aga Bulti, Tefera Mulugeta DemelewJournal of Cancer Prevention 2020; 25(1): 38-47 https://doi.org/10.15430/JCP.2020.25.1.38
Hee Jin Son, Nayoung Kim, Chin-Hee Song, Ryoung Hee Nam, Soo In Choi, Joo Sung Kim, Dong Ho LeeJ Cancer Prev 2019; 24(3): 173-182 https://doi.org/10.15430/JCP.2019.24.3.173
Yehyun Park, Soo Jung Park, Jae Hee Cheon, Won Ho Kim, Tae Il KimJ Cancer Prev 2019; 24(1): 1-10 https://doi.org/10.15430/JCP.2019.24.1.1